AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

3-O-Methyl Norbuprenorphine manufacturers and suppliers on PharmaCompass

PharmaCompass
3-O-Methyl Norbuprenorphine
Also known as: 16614-59-8, 2-[(1s,2s,6r,14r,15r,16r)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]-3,3-dimethylbutan-2-ol, Schembl9986908, Dtxsid40673055
Molecular Formula
C26H37NO4
Molecular Weight
427.6  g/mol
InChI Key
GUFHEIAUPRGDNQ-ALONWEKESA-N

1 2D Structure

3-O-Methyl Norbuprenorphine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(1S,2S,6R,14R,15R,16R)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]-3,3-dimethylbutan-2-ol
2.1.2 InChI
InChI=1S/C26H37NO4/c1-22(2,3)23(4,28)17-14-24-9-10-26(17,30-6)21-25(24)11-12-27-18(24)13-15-7-8-16(29-5)20(31-21)19(15)25/h7-8,17-18,21,27-28H,9-14H2,1-6H3/t17-,18-,21-,23?,24-,25+,26-/m1/s1
2.1.3 InChI Key
GUFHEIAUPRGDNQ-ALONWEKESA-N
2.1.4 Canonical SMILES
CC(C)(C)C(C)(C1CC23CCC1(C4C25CCNC3CC6=C5C(=C(C=C6)OC)O4)OC)O
2.1.5 Isomeric SMILES
CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN[C@@H]3CC6=C5C(=C(C=C6)OC)O4)OC)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 16614-59-8

2. 2-[(1s,2s,6r,14r,15r,16r)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]-3,3-dimethylbutan-2-ol

3. Schembl9986908

4. Dtxsid40673055

2.3 Create Date
2010-07-06
3 Chemical and Physical Properties
Molecular Weight 427.6 g/mol
Molecular Formula C26H37NO4
XLogP34.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass427.27225866 g/mol
Monoisotopic Mass427.27225866 g/mol
Topological Polar Surface Area60 Ų
Heavy Atom Count31
Formal Charge0
Complexity767
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Iran
Digital Content Digital Content
16614-59-8
3-O-Methyl Norbuprenorphine
Parand Daro Pharmaceutical Company is a knowledge-based company that commenced operations in 2015, focusi...
Parand Daro Pharmaceutical Company is a knowledge-based company that commenced operations in 2015, focusing on the production of narcotic medicinal substances. Parand Daro holds the distinction of being the second private sector company in Iran to obtain a license from the Food and Drug Organization to manufacture narcotic products. Leveraging opioid raw materials, Parand Daro has successfully produced potent medicinal substances, including codeine phosphate, noscapine, thebaine, papaverine and oxycodone. Apart from catering to domestic demand, Parand Daro has also expanded its reach by exporting its products to global markets.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY